[go: up one dir, main page]

BR9913072A - Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia - Google Patents

Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia

Info

Publication number
BR9913072A
BR9913072A BR9913072-6A BR9913072A BR9913072A BR 9913072 A BR9913072 A BR 9913072A BR 9913072 A BR9913072 A BR 9913072A BR 9913072 A BR9913072 A BR 9913072A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
ring systems
azacyclic ring
induce analgesia
analgesia
Prior art date
Application number
BR9913072-6A
Other languages
English (en)
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong Cai
George Mark Latham
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of BR9913072A publication Critical patent/BR9913072A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"SISTEMAS DE ANEL AZACìCLICO, COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA INDUZIR A ANALGESIA". A presente invenção fornece novos compostos e composições farmacêuticas destes, úteis no tratamento da dor. Os compostos da presente invenção são azaadamantanos, azanoradamantanos e azaomoadamantanos.
BR9913072-6A 1998-08-18 1999-08-16 Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia BR9913072A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
BR9913072A true BR9913072A (pt) 2001-05-15

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913072-6A BR9913072A (pt) 1998-08-18 1999-08-16 Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia

Country Status (30)

Country Link
US (5) US6093724A (pt)
EP (1) EP1112272B1 (pt)
JP (1) JP2002523416A (pt)
KR (1) KR20010072784A (pt)
CN (1) CN1312812A (pt)
AR (1) AR020199A1 (pt)
AT (1) ATE227724T1 (pt)
AU (1) AU750566B2 (pt)
BG (1) BG105256A (pt)
BR (1) BR9913072A (pt)
CA (1) CA2340946A1 (pt)
CO (1) CO5130018A1 (pt)
DE (1) DE69903961T2 (pt)
EE (1) EE200100096A (pt)
ES (1) ES2191455T3 (pt)
HK (1) HK1038918A1 (pt)
HU (1) HUP0103203A3 (pt)
ID (1) ID27544A (pt)
IL (1) IL141050A0 (pt)
IS (1) IS5827A (pt)
NO (1) NO20010804L (pt)
NZ (1) NZ509762A (pt)
PE (1) PE20000988A1 (pt)
PL (1) PL346247A1 (pt)
RU (1) RU2219179C2 (pt)
SK (1) SK1892001A3 (pt)
TR (1) TR200100462T2 (pt)
WO (1) WO2000011001A1 (pt)
YU (1) YU13301A (pt)
ZA (1) ZA200100978B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20053617B (en) * 2000-10-19 2005-09-26 Pfizer Prod Inc Bridged Piperazine Derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
CN101641356B (zh) 2007-03-23 2012-09-05 雅培制药有限公司 氮杂金刚烷的乙酰胺和甲酰胺衍生物及其使用方法
US8163915B2 (en) * 2007-03-23 2012-04-24 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
WO2010145208A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
SG188307A1 (en) * 2010-09-23 2013-04-30 Abbvie Inc Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
US11325896B2 (en) 2017-12-20 2022-05-10 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
WO2020069301A1 (en) 2018-09-28 2020-04-02 Karuna Therapeutics, Inc. Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
AU702720B2 (en) * 1995-11-02 1999-03-04 Neurosearch A/S Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
ID27544A (id) 2001-04-12
NO20010804L (no) 2001-04-11
AU750566B2 (en) 2002-07-25
HUP0103203A3 (en) 2002-10-28
YU13301A (sh) 2005-06-10
AU5775899A (en) 2000-03-14
CN1312812A (zh) 2001-09-12
ATE227724T1 (de) 2002-11-15
SK1892001A3 (en) 2001-11-06
KR20010072784A (ko) 2001-07-31
ZA200100978B (en) 2002-02-05
NO20010804D0 (no) 2001-02-16
WO2000011001A1 (en) 2000-03-02
AR020199A1 (es) 2002-05-02
US6555550B1 (en) 2003-04-29
IL141050A0 (en) 2002-02-10
US6423842B1 (en) 2002-07-23
HK1038918A1 (zh) 2002-04-04
CO5130018A1 (es) 2002-02-27
EE200100096A (et) 2002-06-17
JP2002523416A (ja) 2002-07-30
CA2340946A1 (en) 2000-03-02
PE20000988A1 (es) 2000-09-30
EP1112272B1 (en) 2002-11-13
NZ509762A (en) 2002-12-20
US20020045617A1 (en) 2002-04-18
DE69903961D1 (de) 2002-12-19
IS5827A (is) 2001-01-26
US6093724A (en) 2000-07-25
TR200100462T2 (tr) 2001-09-21
BG105256A (en) 2001-11-30
US6251916B1 (en) 2001-06-26
DE69903961T2 (de) 2003-07-03
ES2191455T3 (es) 2003-09-01
PL346247A1 (en) 2002-01-28
RU2219179C2 (ru) 2003-12-20
EP1112272A1 (en) 2001-07-04
HUP0103203A2 (hu) 2002-01-28
US6323194B1 (en) 2001-11-27

Similar Documents

Publication Publication Date Title
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BR9814375A (pt) Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
NZ503651A (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
BR9804437A (pt) Compostos para a osteoporose
SE9802729D0 (sv) Novel Compounds
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
SE9802937D0 (sv) Novel compounds
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR9915436A (pt) Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
BR0111897A (pt) Composto, método para tratar um indivìduo afligido por alguns distúrbios dos sistemas nervosos periférico e central, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.